Glactone Pharma Glactone Pharma is a biotech company. It develops a pipeline of STAT3 inhibitors for the use in immuno-oncology and for the treatment of drug-resistant cancers. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ![]() Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | TRON TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1781 | Founding Date 1986 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Helsingborg, SE HQ | Locations New York, US HQ Billerica, US | Locations Mainz, DE HQ | |
Employees | Employees 6 | Employees 47,4554% decrease | Employees 49 | Employees 1903% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) $35m (FY, 2019) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥850.5b (FY, 2026) | Cost of goods $3.2m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥3.7t (FY, 2026) | Gross profit $31.8m (FY, 2019) | Gross profit N/A |
Net income | Net income N/A | Net income ¥192b (FY, 2026) | Net income ($68.6m) (FY, 2019) | Net income N/A |

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View companyTRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases.
View company